Compare Heron Therapeutics Inc (HRTX) vs iShares MSCI India ETF (INDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs iShares MSCI India ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares MSCI India ETF trades at $50.06. The key difference: iShares MSCI India ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | INDA | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.49 | $55.29 |
52-Week Low | $0.32 | $45.42 |
Enterprise Value | $168.21M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →
